NL
NL · NL · NL-87db9f8a3ef9
Tezspire, 110 mg/ml, oplossing voor injectie
ATC R03DX11
Last synced from CBG-MEB (Netherlands) on
Identification
ManufacturerAstraZeneca AB
CountryNL (NL)
ATC codeR03DX11
Dispensing—
ReimbursedNo
SourceCBG-MEB (Netherlands)
Last synced6/9/2026
Packs · 1
- cbg_meb_idEU/1/22/1677
Annotations
No annotations yet.
Raw payload (JSON)
{
"form": "Oplossing voor injectie",
"route": "Subcutaan gebruik",
"soort": null,
"source": "cbg_meb",
"smpc_url": "https://www.ema.europa.eu/en/documents/product-information/tezspire-epar-product-information_nl.pdf",
"strength": null,
"atc_label": "Tezepelumab",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp128439",
"excipients": [
"AZIJNZUUR (E 260), GECONCENTREERD",
"NATRIUMHYDROXIDE (E 524)",
"POLYSORBAAT 80 (E 433)",
"PROLINE, (L-)",
"WATER VOOR INJECTIE"
],
"substances": [
"TEZEPELUMAB"
],
"leaflet_url": null,
"authorised_at": "2022/09/19",
"procedure_number": "EMEA/H/C/005588",
"dispensing_status": "Uitsluitend recept",
"registration_number": "EU/1/22/1677",
"additional_monitoring": "Y"
}Related drugs
Other records sharing ATC code R03DX11.
Access this data programmatically
Query Tezspire, 110 mg/ml, oplossing voor injectie and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.